Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (231-240 of 441) with videos related to

Pageof 45
Sort By:
Journal of Experimental Therapeutics & Oncology|January 15, 2014
The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasisFredika M Robertson, Khoi Chu, Kimberly M Boley, et al.
Breast Cancer Research : BCR|December 6, 2019
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancerAndrew A Davis, Qiang Zhang, Lorenzo Gerratana, et al.
Cancer Treatment Reviews|January 26, 2019
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?Giuseppe Buono, Lorenzo Gerratana, Michela Bulfoni, et al.
Molecular Oncology|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept studyDimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, et al.
Clinical Chemistry|September 26, 2019
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA AnalysisBen O'Leary, Sarah Hrebien, Matthew Beaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survivalDaniel F Hayes, Massimo Cristofanilli, G Thomas Budd, et al.
Neuro-Oncology Practice|September 27, 2019
Current state of clinical trials in breast cancer brain metastasesJawad Fares, Deepak Kanojia, Alex Cordero, et al.
Cancer|January 31, 2006
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapyBryan T Hennessy, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, et al.
JAMA Oncology|May 26, 2018
Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast CancerChelain R Goodman, Brandon-Luke L Seagle, Thomas W P Friedl, et al.
NPJ Precision Oncology|May 25, 2026
Circulating cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-seq) in oncology: from technological advances to clinical applicationsEdoardo Francini, Sara Bleve, Giuseppe Nicolo Fanelli, et al.
Pageof 45

Showing results (231-240 of 441) with videos related to

Sort By:
Pageof 45
Journal of Experimental Therapeutics & Oncology|January 15, 2014
The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasisFredika M Robertson, Khoi Chu, Kimberly M Boley, et al.
Breast Cancer Research : BCR|December 6, 2019
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancerAndrew A Davis, Qiang Zhang, Lorenzo Gerratana, et al.
Cancer Treatment Reviews|January 26, 2019
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?Giuseppe Buono, Lorenzo Gerratana, Michela Bulfoni, et al.
Molecular Oncology|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept studyDimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, et al.
Clinical Chemistry|September 26, 2019
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA AnalysisBen O'Leary, Sarah Hrebien, Matthew Beaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survivalDaniel F Hayes, Massimo Cristofanilli, G Thomas Budd, et al.
Neuro-Oncology Practice|September 27, 2019
Current state of clinical trials in breast cancer brain metastasesJawad Fares, Deepak Kanojia, Alex Cordero, et al.
Cancer|January 31, 2006
Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapyBryan T Hennessy, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, et al.
JAMA Oncology|May 26, 2018
Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast CancerChelain R Goodman, Brandon-Luke L Seagle, Thomas W P Friedl, et al.
NPJ Precision Oncology|May 25, 2026
Circulating cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-seq) in oncology: from technological advances to clinical applicationsEdoardo Francini, Sara Bleve, Giuseppe Nicolo Fanelli, et al.
Pageof 45